L&K Biomed Ltd. (KOSDAQ:156100)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,070.00
-280.00 (-2.99%)
At close: Mar 19, 2026

L&K Biomed Revenue

In the year 2025, L&K Biomed had annual revenue of 38.92B KRW with 7.84% growth. L&K Biomed had revenue of 8.61B in the quarter ending December 31, 2025, a decrease of -14.11%.

Revenue
38.92B
Revenue Growth
+7.84%
P/S Ratio
5.23
Revenue / Employee
385.35M
Employees
101
Market Cap
203.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202538.92B2.83B7.84%
Dec 31, 202436.09B6.19B20.69%
Dec 31, 202329.90B10.14B51.28%
Dec 31, 202219.77B4.39B28.59%
Dec 31, 202115.37B-3.98B-20.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
DRGEM102.75B
MEDIANA Co.,Ltd64.94B
JPI Healthcare52.79B
ASTERASYS Co.,Ltd37.94B
Hironic33.18B
SELVAS Healthcare29.79B
Remed24.26B
Neofect16.05B
Revenue Rankings